6 assets in Liver Failure

Therapeutic assets addressing Liver Failure, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Empagliflozin Liver Failure	Yale University	P4	BB (71)
Regorafenib Liver Failure	Ju Hyun Shim	P2	CCC (53)
Carboplatin Liver Failure	National Cancer Institute (NCI)	P1	CC (43)
Incb123667 Liver Failure	Incyte Corporation	P1	CC (43)
Veliparib Liver Failure	National Cancer Institute (NCI)	P1	CC (43)
Mdr-001 Liver Failure	MindRank AI Ltd	P1	NR ()